<p><b>Kaplan-Meier curves for ESRD requiring RRT (A) and composite outcome (ESRD or all-cause mortality or hospitalization for hyperkalemia) (B) in propensity score matching cohort.</b> ACEI/ARB users showed higher risk of renal mortality (A) and composite outcome (B) than non-users.</p
Abstract: Long-term benefit of using a renin–angiotensin–aldoster-one system blocker such as an angi...
BackgroundAngiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ACEi/ARB) impr...
Background: Acute kidney injury (AKI) may increase the risk of chronic kidney disease (CKD), develop...
Renin-angiotensin-system (RAS) blockade is thought to slow renal progression in patients with chroni...
[[abstract]]Dual renin angiotensin system (RAS) blockade using angiotensin-receptor blockers (ARBs) ...
<div><p>Renin-angiotensin-system (RAS) blockade is thought to slow renal progression in patients wit...
[[abstract]]IMPORTANCE The benefit of using a renin-angiotensin-aldosterone system blocker such as a...
ObjectivesThe study objective was to assess the association between angiotensin-converting enzyme in...
ObjectivesThe study objective was to assess the association between angiotensin-converting enzyme in...
Background/Aims: Whether angiotensin converting enzyme inhibitors (ACE) and angiotensin receptor blo...
<p><b>Hazard ratios and 95% confidence intervals comparing ACEI therapy with ARB therapy for study o...
Long-term benefit of using a renin angiotensin aldosterone system blocker such as an angiotensin-con...
IntroductionAngiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) ...
To compare the relative effectiveness of angiotensin-converting enzyme inhibitors (ACEIs) and angiot...
[[abstract]]Objective: The aim of this study was to explore the respective use of angiotensin-conver...
Abstract: Long-term benefit of using a renin–angiotensin–aldoster-one system blocker such as an angi...
BackgroundAngiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ACEi/ARB) impr...
Background: Acute kidney injury (AKI) may increase the risk of chronic kidney disease (CKD), develop...
Renin-angiotensin-system (RAS) blockade is thought to slow renal progression in patients with chroni...
[[abstract]]Dual renin angiotensin system (RAS) blockade using angiotensin-receptor blockers (ARBs) ...
<div><p>Renin-angiotensin-system (RAS) blockade is thought to slow renal progression in patients wit...
[[abstract]]IMPORTANCE The benefit of using a renin-angiotensin-aldosterone system blocker such as a...
ObjectivesThe study objective was to assess the association between angiotensin-converting enzyme in...
ObjectivesThe study objective was to assess the association between angiotensin-converting enzyme in...
Background/Aims: Whether angiotensin converting enzyme inhibitors (ACE) and angiotensin receptor blo...
<p><b>Hazard ratios and 95% confidence intervals comparing ACEI therapy with ARB therapy for study o...
Long-term benefit of using a renin angiotensin aldosterone system blocker such as an angiotensin-con...
IntroductionAngiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) ...
To compare the relative effectiveness of angiotensin-converting enzyme inhibitors (ACEIs) and angiot...
[[abstract]]Objective: The aim of this study was to explore the respective use of angiotensin-conver...
Abstract: Long-term benefit of using a renin–angiotensin–aldoster-one system blocker such as an angi...
BackgroundAngiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ACEi/ARB) impr...
Background: Acute kidney injury (AKI) may increase the risk of chronic kidney disease (CKD), develop...